Ethnic differences in immune responses to hepatitis B vaccine

American Journal of Epidemiology

Volumn 143, Issue 7, 1996, Pages 718-724

  Hsu, Li Ching ^a   Lin, Sheue Rong ^b   Hsu, Hsu Mei ^b   Chao, Wan Hwa ^a,c   Hsieh, Jung Tian ^d   Wang, Ming Ching ^a   Lu, Chih Feng ^a   Chang, Yao Hsiung ^b   Ho, Mei Shang ^a,c,e  

^a DEPARTMENT OF HEALTH   (Taiwan)

^b Ministry of Health Taiwan   (Taiwan)

^c ACADEMIA SINICA   (Taiwan)

^d DEPARTMENT OF HEALTH   (Taiwan)

^e INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

antibodies; diphtheria; encephalitis viruses, Japanese; ethnic groups; hepatitis B vaccines; hepatitis B virus

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; JAPANESE ENCEPHALITIS VACCINE;

ABORIGINE; ANTIBODY TITER; ARTICLE; CHINA; CLINICAL TRIAL; ETHNIC DIFFERENCE; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; IMMUNE RESPONSE; MALE; NORMAL HUMAN; PRESCHOOL CHILD; TREATMENT OUTCOME; VACCINATION;

EID: 0029980736     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a008805     Document Type: Article

References (33)

1. Szmuness W, Stevens CE, Harley EJ, et al. Hepatitis B vaccine in medical staff of hemodialysis units: efficacy and cross-protection. N Engl J Med 1982;307:1481-6.
2. Hsu HM, Chen DS, Chuang CH, et al. Efficacy of a mass hepatitis B vaccination program in Taiwan. Studies on 3464 infants of hepatitis B surface antigen-carrier mothers. JAMA 1988;260:2231-5.
3. Chan CY, Lee SD, Tsai YT, et al. Long-term follow-up of hepatitis B vaccination in infants born to noncarrier mothers in Taiwan. Chin Med J (Engl) 1992;50:83-8.
4. Goldwater PN. Randomized comparative trial of interferonalpha versus placebo in hepatitis B vaccine non-responders and hyporesponders. Vaccine 1994;12:410-14.
5. Pasco MT, Pharm D, Beam TR. Persistence of anti-HBs among health care personnel immunized with hepatitis B vaccine. Am J Public Health 1990;80:590-3.
6. Nalpas B, Thepot V, Driss F, et al. Secondary immune response to hepatitis B virus vaccine in alcoholics. Alcoholism 1993;17:295-8.
7. Hollinger FB. Factors influencing the immune response to hepatitis B vaccine, booster dose guidelines, and vaccine protocol recommendations. Am J Med 1989;87;36-40S.
8. Shaw FJ, Guess H, Roets J, et al. Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccination. Vaccine 1989;7:425-30.
9. Bouter KP, Diepersloot RJ, Wismans PJ, et al. Humoral immune response to a yeast-derived hepatitis B vaccine in patients with type I diabetes mellitus. Diabet Med 1992;9:66-9.
10. Kurz P, Kohler H, Meuer S, et al. Impaired cellular immune responses in chronic renal failure: evidence for a T cell defect. Kidney Int 1986;29:1209-14.
11. Egea E, Iglesias A, Salazar M, et al. The cellular basis for lack of antibody response to hepatitis B vaccine in humans. J Exp Med 1991;173:531-8.
12. Alper CA, Kruskall MS, Marcus-Bagley D, et al. Genetic prediction of nonresponse to hepatitis B vaccine. N Engl J Med 1989;321:708-12.
13. Greenberg DP. Pediatric experience with recombinant hepatitis B vaccines and relevant safety and immunogenicity studies. Pediatr Infect Dis J 1993;12:438-45.
14. Lo K-J, Tsai Y-T, Lee S-D, et al. Immunoprophylaxis of infection with hepatitis B virus in infants born to hepatitis B surface antigen-positive carrier mothers. J Infect Dis 1985; 152:817-22.
15. Schalm SW, Mazel JA, de Gast GC, et al. Prevention of hepatitis B injection in newborns through mass screening and delayed vaccination of all infants of mothers with hepatitis B surface antigen. Pediatrics 1989;83:1041-8.
16. Lagergard T, Trollfors B, Claesson BA, et al. Determination of neutralizing antibodies and specific immunoglobulin iso-type levels in infants after vaccination against diphtheria. Eur J Clin Microbiol Infect Dis 1992;11:341-5.
17. Stevens CE, Toy PT, Taylor PE, et al. Prospects for control of hepatitis B virus infection: implications of childhood vaccination and long term protection. Pediatrics 1992;90:170-3.
18. Lo KJ, Lee SD, Tsai YT, et al. Long-term immunogenicity and efficacy of hepatitis B vaccine in infants born to HBeAgpositive HBsAg-carrier mothers. Hepatology 1988;8:1647-50.
19. Delage G, Remy-Prince S, Montplaisir S. Combined activepassive immunization against the hepatitis B virus: five-year follow-up of children born to hepatitis B surface antigenpositive mothers. Pediatr Infect Dis J 1993;12:126-30.
20. Grosheide P, del Canho R, Voogd K, et al. Anti-HBs levels in infants of hepatitis B carrier mothers after delayed active immunization with recombinant vaccine concomitant with DTP-polio vaccine: is there need for a second dose of HBIg? Vaccine 1994;12:1059-63.
21. Payton C, Scarisbrick D, Sikotra S, et al. Vaccination against hepatitis B: comparison of intradermal and intramuscular administration of plasma derived and recombinant vaccines. Epidemiol Infect 1993;110:177-80.
22. Panda S, Ramesh R, Rao K, et al. Comparative evaluation of the immunogenicity of yeast-derived (recombinant) and plasma-derived hepatitis B vaccine in infants. J Med Virol 1991; 35:297-302.
23. Ukena T, Esber H, Besserte R, et al. Site of injection and response to hepatitis B vaccine. N Engl J Med 1985;313: 579-80.
24. Craven D, Awdwh Z, Kunches L, et al. Nonresponsiveness to hepatitis B vaccine in health care workers. Ann Intern Med 1986;105:356-60.
25. Wismans P, van Hattum J, Stelling T, et al. Effect of supplementary vaccination in healthy non-responders to hepatitis B vaccination. Hepatogasrroenterology 1988;35:78-9.
26. Zuin G, Principi N, Tornaghi R, et al. Impaired response to hepatitis B vaccine in HIV infected children. Vaccine 1992; 10:857-60.
27. Van Thiel D, Gavaler J. Response to HBV vaccination in patients with severe liver disease. Absence of an HLA effect. Dig Dis Sci 1992;37:1447-51.
28. Weber JD, Rutala WA, Samsa GP, et al. Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine. JAMA 1985;254:3187-9.
29. Degos F, Duhamel G, Brechet C, et al. Hepatitis B vaccination in chrome alcoholics. J Hepatol 1986;2:402-9.
30. Kruskall MS, Alper CA, Awdeh Z, et al. The immune response to hepatitis B vaccine in humans: inheritance patterns in families. J Exp Med 1992;175:495-502.
31. Lin HH, Wu JS, Lu CF, et al. Hepatitis B virus infection among aboriginal children in eastern Taiwan. J Formes Med Assoc 1992;91-691-3.
32. Chen C-J, You C-Y, You S-L, et al. Seroepidemiology of hepatitis A, A and D viruses among children in Taiwan. In: Sung J-L, Chen D-S, eds. Viral hepatitis and hepatocellular carcinoma. Excerpta Medica 1988;9-15.
33. Sehgal A, Gupta I, Sehgal R, et al. Hepatitis B vaccine alone or in combination with anti-HBs immunoglobulin in the perinatal prophylaxis of babies born to HBsAg carrier mothers. Acta Virol 1992;36:359-66.